Real-world persistence of multiple sclerosis disease-modifying therapies.
Emma Clare TallantyreChu-Yueh GuoJoseph L J FroudFrederika A St JohnValerie M AndersonTarunya ArunLauren BuckleyNikos EvangelouHelen L FordIan GaleaSumi GeorgeOrla M GrayAimee M HibbertMo HuStella E HughesGillian IngramSeema KalraChia-Hui E LimJoela T M MathewsGavin V McDonnellNaomi MescallSam NorrisStephen J RamsayClaire M RiceMelanie J RussellMarianne J Shawe-TaylorThomas E WilliamsKatharine E HardingNeil P RobertsonPublished in: European journal of neurology (2024)
Immune reconstituting DMTs may have the highest potential to offer a single treatment for relapsing MS. Comparative data on DMT persistence and reasons for discontinuation are valuable to inform treatment decisions and in personalizing treatment in MS.